Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Andrés Felipe Vásquez & Andrés Fernando González Barrios. (2022) Classical MD and metadynamics simulations on back-pocket binders of CDK2 and VEGFR2: a guidepost to design novel small-molecule dual inhibitors. Journal of Biomolecular Structure and Dynamics 40:19, pages 9030-9041.
Read now
Read now
Xiaofeng Xu, Yuhua Yan, Qingying Xun, Jiayu Shi, Xiangyi Kong, Jun Wu & Huaijun Zhou. (2019) Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line. OncoTargets and Therapy 12, pages 1215-1223.
Read now
Read now
Panrong Zhu, Chenxi Hu, Kaiyuan Hui & Xiaodong Jiang. (2017) The role and significance of VEGFR2+ regulatory T cells in tumor immunity. OncoTargets and Therapy 10, pages 4315-4319.
Read now
Read now
Articles from other publishers (51)
Nahed S. Alharthi, Maryam Hassan Al-Zahrani, Ali Hazazi, Hayaa Moeed Alhuthali, Amal F. Gharib, Shatha alzahrani, Wafa Altalhi, Waleed Hassan Almalki & Farhan R. Khan. (2024) Exploring the lncRNA-VEGF axis: Implications for cancer detection and therapy. Pathology - Research and Practice 253, pages 154998.
Crossref
Crossref
Binhao Chen & Weifeng Jin. (2023) A comprehensive review of stroke-related signaling pathways and treatment in western medicine and traditional Chinese medicine. Frontiers in Neuroscience 17.
Crossref
Crossref
Lei Lei, Qing Cao, Guoyan An, Yuejiao Lv, Juan Tang & Jin Yang. (2022) DDI2 promotes tumor metastasis and resists antineoplastic drugs-induced apoptosis in colorectal cancer. Apoptosis 28:3-4, pages 458-470.
Crossref
Crossref
Leihao Hu, Canfeng He, Aier Mo, Xingkai Zhan, Caizhi Yang, Wei Guo, Lingling Sun, Weiwei Su & Lizhu Lin. (2023) A Mechanism Exploration for the Yi-Fei-San-Jie Formula against Non-Small-Cell Lung Cancer Based on UPLC-MS/MS, Network Pharmacology, and In Silico Verification. Evidence-Based Complementary and Alternative Medicine 2023, pages 1-16.
Crossref
Crossref
Ming Jing Wang, Yan Sun, Ying Song, Ju Ning Ma, Zi Qing Wang, Xiao Qing Ding, Hai Yan Chen, Xue Bin Zhang, Min Min Song & Xiao Mei Hu. (2022) Mechanism and Molecular Targets of Ejiao Siwu Decoction for Treating Primary Immune Thrombocytopenia Based on High-Performance Liquid Chromatograph, Network Pharmacology, Molecular Docking and Cytokines Validation. Frontiers in Medicine 9.
Crossref
Crossref
Luka Roškar, Irena Roškar, Tea Lanišnik Rižner & Špela Smrkolj. (2021) Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer. Biomolecules 12:1, pages 7.
Crossref
Crossref
Nicholas S. Diab, Syndi Barish, Weilai Dong, Shujuan Zhao, Garrett Allington, Xiaobing Yu, Kristopher T. Kahle, Martina Brueckner & Sheng Chih Jin. (2021) Molecular Genetics and Complex Inheritance of Congenital Heart Disease. Genes 12:7, pages 1020.
Crossref
Crossref
Ruiping Wang, Yue Han, Zhangxiang Zhao, Fan Yang, Tingting Chen, Wenbin Zhou, Xianlong Wang, Lishuang Qi, Wenyuan Zhao, Zheng Guo & Yunyan Gu. (2019) Link synthetic lethality to drug sensitivity of cancer cells. Briefings in Bioinformatics 20:4, pages 1295-1307.
Crossref
Crossref
Ying Wang, Baichun Hu, Yusheng Peng, Xin Xiong, Wenhua Jing, Jian Wang & Huiyuan Gao. (2019) In Silico Exploration of the Molecular Mechanism of Cassane Diterpenoids on Anti-inflammatory and Immunomodulatory Activity. Journal of Chemical Information and Modeling 59:5, pages 2309-2323.
Crossref
Crossref
Ali Mahdi, Behrad Darvishi, Keivan Majidzadeh‐A, Malihe Salehi & Leila Farahmand. (2018) Challenges facing antiangiogenesis therapy: The significant role of hypoxia‐inducible factor and MET in development of resistance to anti‐vascular endothelial growth factor‐targeted therapies. Journal of Cellular Physiology 234:5, pages 5655-5663.
Crossref
Crossref
Mengxia Li, Nan Dai, Dong Wang & Zhaoyang Zhong. (2019) Distinct APE1 Activities Affect the Regulation of VEGF Transcription Under Hypoxic Conditions. Computational and Structural Biotechnology Journal 17, pages 324-332.
Crossref
Crossref
Bessi Qorri & Myron R. Szewczuk. 2019. Current Applications for Overcoming Resistance to Targeted Therapies. Current Applications for Overcoming Resistance to Targeted Therapies
35
61
.
M. Blanca Piazuelo, Rachel P. Riechelmann, Keith T. Wilson & Holly M. Scott Algood. 2019. Molecular Mechanisms of Inflammation: Induction, Resolution and Escape by Helicobacter pylori. Molecular Mechanisms of Inflammation: Induction, Resolution and Escape by Helicobacter pylori
319
359
.
Jianling Zou, Ying Liu, Jingyuan Wang, Zhentao Liu, Zhihao Lu, Zuhua Chen, Zhongwu Li, Bin Dong, Wenwen Huang, Yanyan Li, Jing Gao & Lin Shen. (2018) Establishment and genomic characterizations of patient-derived esophageal squamous cell carcinoma xenograft models using biopsies for treatment optimization. Journal of Translational Medicine 16:1.
Crossref
Crossref
Madhurima Das & Sujata Law. (2018) Role of tumor microenvironment in cancer stem cell chemoresistance and recurrence. The International Journal of Biochemistry & Cell Biology 103, pages 115-124.
Crossref
Crossref
Jong‑Min Park, Yoon Kim, Min Song, Jae‑Min Lee & Youn‑Jung Kim. (2018) Genome‑wide DNA methylation profiling in a rat model with vascular dementia. Molecular Medicine Reports.
Crossref
Crossref
Huaqiang Zhu, Xian Jiang, Xu Zhou, Xuesong Dong, Kai Xie, Chuncheng Yang, Hongchi Jiang, Xueying Sun & Jun Lu. (2018) Neuropilin-1 regulated by miR-320 contributes to the growth and metastasis of cholangiocarcinoma cells. Liver International 38:1, pages 125-135.
Crossref
Crossref
Shimin Wang, Zhi’an Li & Guoming Hu. (2017) Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis. Oncotarget 8:39, pages 66382-66391.
Crossref
Crossref
Ding Wu, Zhan Shi, Hao Xu, Renfu Chen, Song Xue & Xiaoqing Sun. (2017) Knockdown of Cripto-1 inhibits the proliferation, migration, invasion, and angiogenesis in prostate carcinoma cells. Journal of Biosciences.
Crossref
Crossref
Fenil Shah, Derek Logsdon, Richard A. Messmann, Jill C. Fehrenbacher, Melissa L. Fishel & Mark R. Kelley. (2017) Exploiting the Ref-1-APE1 node in cancer signaling and other diseases: from bench to clinic. npj Precision Oncology 1:1.
Crossref
Crossref
Xin Zhang, Zhi‐hua Ye, Hai‐wei Liang, Fang‐hui Ren, Ping Li, Yi‐wu Dang & Gang Chen. (2017)
Down‐regulation of miR‐146a‐5p and its potential targets in hepatocellular carcinoma validated by a
TCGA
‐ and
GEO
‐based study
. FEBS Open Bio 7:4, pages 504-521.
Crossref
Crossref
Guo‑Jian Li, Yong Yang, Guo‑Kai Yang, Jia Wan, Dao‑Lei Cui, Zhen‑Huan Ma, Ling‑Juan Du & Gui‑Min Zhang. (2017) Slit2 suppresses endothelial cell proliferation and migration by inhibiting the VEGF-Notch signaling pathway. Molecular Medicine Reports.
Crossref
Crossref
Nikol Snoeren, Richard van Hillegersberg, Sander B. Schouten, Andre M. Bergman, Erikv van Werkhoven, Otilia Dalesio, Rob A.E.M. Tollenaar, Henk M. Verheul, Joost van der Sijp, Inne H.M. Borel Rinkes & E.E. Voest. (2017) Randomized Phase III Study to Assess Efficacy and Safety of Adjuvant CAPOX with or without Bevacizumab in Patients after Resection of Colorectal Liver Metastases: HEPATICA study. Neoplasia 19:2, pages 93-99.
Crossref
Crossref
Mary Rusckowski, Yuzhen Wang, Francis G. Blankenberg, Zoia Levashova, Marina V. Backer & Joseph M. Backer. (2016) Targeted scVEGF/177Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy. EJNMMI Research 6:1.
Crossref
Crossref
Jerusha Boyineni, Smita Tanpure, Manu Gnanamony, Reuben Antony, Karen S. Fernández, Julian Lin, David Pinson & Christopher S. Gondi. (2016) SPARC overexpression combined with radiation retards angiogenesis by suppressing VEGF-A via miR-410 in human neuroblastoma cells. International Journal of Oncology 49:4, pages 1394-1406.
Crossref
Crossref
Camille Tlemsani, Olivier Mir, Dimitri Psimaras, Yann-Alexandre Vano, Michel Ducreux, Bernard Escudier, Benoit Rousseau, Delphine Loirat, Bernard Ceccaldi, Thierry André, François Goldwasser & Damien Ricard. (2016) Acute neurovascular events in cancer patients receiving anti-vascular endothelial growth factor agents: Clinical experience in Paris University Hospitals. European Journal of Cancer 66, pages 75-82.
Crossref
Crossref
R. A. Everett, J. D. Nagy & Y. Kuang. (2015) Dynamics of a Data Based Ovarian Cancer Growth and Treatment Model with Time Delay. Journal of Dynamics and Differential Equations 28:3-4, pages 1393-1414.
Crossref
Crossref
Mythili Kameswaran, Usha Pandey, Naresh Gamre, K.V. Vimalnath, Haladhar Dev Sarma & Ashutosh Dash. (2016) Evaluation of 177Lu-CHX-A′′-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancers. Applied Radiation and Isotopes 114, pages 196-201.
Crossref
Crossref
Xin Zhang, Wei Tang, Gang Chen, Fanghui Ren, Haiwei Liang, Yiwu Dang & Minhua Rong. (2016) An Encapsulation of Gene Signatures for Hepatocellular Carcinoma, MicroRNA-132 Predicted Target Genes and the Corresponding Overlaps. PLOS ONE 11:7, pages e0159498.
Crossref
Crossref
Valerie Sloane Jones, Ren-Yu Huang, Li-Pai Chen, Zhe-Sheng Chen, Liwu Fu & Ruo-Pan Huang. (2016) Cytokines in cancer drug resistance: Cues to new therapeutic strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1865:2, pages 255-265.
Crossref
Crossref
Filippa Fleetwood, Rezan Güler, Emma Gordon, Stefan Ståhl, Lena Claesson-Welsh & John Löfblom. (2015) Novel affinity binders for neutralization of vascular endothelial growth factor (VEGF) signaling. Cellular and Molecular Life Sciences 73:8, pages 1671-1683.
Crossref
Crossref
ZHI ZHANG, HANGUANG ZHANG, TAO PENG, DONGDONG LI & JING XU. (2016) Melittin suppresses cathepsin S-induced invasion and angiogenesis via blocking of the VEGF-A/VEGFR-2/MEK1/ERK1/2 pathway in human hepatocellular carcinoma. Oncology Letters 11:1, pages 610-618.
Crossref
Crossref
Shuai Zhao, Dang Wu, Pin Wu, Zhen Wang & Jian Huang. (2015) Serum IL-10 Predicts Worse Outcome in Cancer Patients: A Meta-Analysis. PLOS ONE 10:10, pages e0139598.
Crossref
Crossref
Wanwei Zhang, Tao Zeng, Xiaoping Liu & Luonan Chen. (2015) Diagnosing phenotypes of single-sample individuals by edge biomarkers. Journal of Molecular Cell Biology 7:3, pages 231-241.
Crossref
Crossref
Victoria Youngblood, Shan Wang, Wenqiang Song, Debra Walter, Yoonha Hwang, Jin Chen & Dana M. Brantley-Sieders. (2015) Elevated Slit2 Activity Impairs VEGF-Induced Angiogenesis and Tumor Neovascularization in EphA2-Deficient Endothelium. Molecular Cancer Research 13:3, pages 524-537.
Crossref
Crossref
S Torok, A Vegvari, M Rezeli, T E Fehniger, J Tovari, S Paku, V Laszlo, B Hegedus, A Rozsas, B Dome & G Marko-Varga. (2015) Localization of sunitinib, its metabolites and its target receptors in tumour-bearing mice: a MALDI-MS imaging study. British Journal of Pharmacology 172:4, pages 1148-1163.
Crossref
Crossref
Brandon Beagle & David A. Fruman. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia
335
362
.
Stephan D. Voss, Julia Glade-Bender, Sheri L. Spunt, Steven G. DuBois, Brigitte C. Widemann, Julie R. Park, Sarah E. S. Leary, Marvin D. Nelson, Peter C. Adamson, Susan M. Blaney & Brenda Weigel. (2015) Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: A report from the children's oncology group phase I consortium. Pediatric Blood & Cancer 62:1, pages 45-51.
Crossref
Crossref
Victor H. Guaiquil, Zan Pan, Natalia Karagianni, Shima Fukuoka, Gemstonn Alegre & Mark I. Rosenblatt. (2014) VEGF-B selectively regenerates injured peripheral neurons and restores sensory and trophic functions. Proceedings of the National Academy of Sciences 111:48, pages 17272-17277.
Crossref
Crossref
Qu Zhang, Hua Li, Hong Jin, Huibiao Tan, Jun Zhang & Sitong Sheng. (2014) The global landscape of intron retentions in lung adenocarcinoma. BMC Medical Genomics 7:1.
Crossref
Crossref
D. Georgiadou, T.N. Sergentanis, S. Sakellariou, G.M. Filippakis, F. Zagouri, D. Vlachodimitropoulos, T. Psaltopoulou, A.C. Lazaris, E. Patsouris & G.C. Zografos. (2014) VEGF and Id-1 in pancreatic adenocarcinoma: Prognostic significance and impact on angiogenesis. European Journal of Surgical Oncology (EJSO) 40:10, pages 1331-1337.
Crossref
Crossref
Patricia M. LoRusso, Smitha Krishnamurthi, Hagop Youssoufian, Nancy Hall, Floyd Fox, Aruna Dontabhaktuni, Dmitri Grebennik & Scot Remick. (2013) Icrucumab, a fully human monoclonal antibody against the vascular endothelial growth factor receptor-1, in the treatment of patients with advanced solid malignancies: a Phase 1 study. Investigational New Drugs 32:2, pages 303-311.
Crossref
Crossref
Sandra Torijano-Gutiérrez, Santiago Díaz-Oltra, Eva Falomir, Juan Murga, Miguel Carda & J. Alberto Marco. (2013) Synthesis of combretastatin A-4 O-alkyl derivatives and evaluation of their cytotoxic, antiangiogenic and antitelomerase activity. Bioorganic & Medicinal Chemistry 21:23, pages 7267-7274.
Crossref
Crossref
Matthias W. Laschke, Antonia E. Vorsterman van Oijen, Christina Körbel, Claudia Scheuer & Michael D. Menger. (2013) 4-Hydroxybenzyl alcohol: A novel inhibitor of tumor angiogenesis and growth. Life Sciences 93:1, pages 44-50.
Crossref
Crossref
Rosa Martí-Centelles, Rocío Cejudo-Marín, Eva Falomir, Juan Murga, Miguel Carda & J. Alberto Marco. (2013) Inhibition of VEGF expression in cancer cells and endothelial cell differentiation by synthetic stilbene derivatives. Bioorganic & Medicinal Chemistry 21:11, pages 3010-3015.
Crossref
Crossref
FUQIANG YIN, XIA LIU, DANRONG LI, QI WANG, WEI ZHANG & LI LI. (2013) Bioinformatic analysis of chemokine (C-C motif) ligand 21 and SPARC-like protein 1 revealing their associations with drug resistance in ovarian cancer. International Journal of Oncology 42:4, pages 1305-1316.
Crossref
Crossref
Y. Liu, M. Suzuki, S.-i. Masunaga, Y.-W. Chen, G. Kashino, H. Tanaka, Y. Sakurai, M. Kirihata & K. ONO. (2012) Effect of bevacizumab treatment on p-boronophenylalanine distribution in murine tumor. Journal of Radiation Research 54:2, pages 260-267.
Crossref
Crossref
Hubert Hondermarck. (2012) Neurotrophins and their receptors in breast cancer. Cytokine & Growth Factor Reviews 23:6, pages 357-365.
Crossref
Crossref
Li-Hong Zhou, Qiang Hu, Hua Sui, Shu-Jun Ci, Yan Wang, Xuan Liu, Ning-Ning Liu, Pei-Hao Yin, Jian-Min Qin & Qi Li. (2012) Tanshinone II-A Inhibits Angiogenesis through Down Regulation of COX-2 in Human Colorectal Cancer. Asian Pacific Journal of Cancer Prevention 13:9, pages 4453-4458.
Crossref
Crossref
Jaya Prabhakaran, Victoria Arango, Vattoly J. Majo, Norman R. Simpson, Suham A. Kassir, Mark D. Underwood, Hanish Polavarapu, Jeffrey N. Bruce, Peter Canoll, J. John Mann & J.S. Dileep Kumar. (2012) Synthesis and in vitro evaluation of [18F](R)-FEPAQ: A potential PET ligand for VEGFR2. Bioorganic & Medicinal Chemistry Letters 22:15, pages 5104-5107.
Crossref
Crossref
David Shahbazian, Joshua Sznol & Harriet M. Kluger. 2012. Current Challenges in Personalized Cancer Medicine. Current Challenges in Personalized Cancer Medicine
1
26
.